Jefferies Group's ETON Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 34,027 shares of Eton Pharmaceuticals, Inc. (ETON) worth $1.23 M, representing 0.01% of the portfolio. First purchased in 2024-Q4, this short-term holding has been held for 7 quarters.
Based on 13F filings, Jefferies Group has maintained this position in ETON for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 88,440 shares. Largest reduction occurred in Q1 2026, reducing 118,300 shares.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Eton Pharmaceuticals (ETON) Holding Value Over Time
Track share changes against reported price movement
Quarterly Eton Pharmaceuticals (ETON) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +34,027 | New Buy | 34,027 | $36.20 |
| Q1 2026 | -118,300 | Sold Out | 0 | $0.00 |
| Q4 2025 | +29,860 | Add 33.76% | 118,300 | $16.91 |
| Q3 2025 | +88,440 | New Buy | 88,440 | $21.73 |
| Q2 2025 | -10,000 | Sold Out | 0 | $0.00 |
| Q4 2024 | +10,000 | New Buy | 10,000 | $13.32 |
Jefferies Group's Eton Pharmaceuticals Investment FAQs
Jefferies Group first purchased Eton Pharmaceuticals, Inc. (ETON) in Q4 2024, acquiring 10,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Eton Pharmaceuticals, Inc. (ETON) for 7 quarters since Q4 2024.
Jefferies Group's largest addition to Eton Pharmaceuticals, Inc. (ETON) was in Q3 2025, adding 88,440 shares worth $1.92 M.
According to the latest 13F filing for Q2 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 34,027 shares of Eton Pharmaceuticals, Inc. (ETON), valued at approximately $1.23 M.
As of the Q2 2026 filing, Eton Pharmaceuticals, Inc. (ETON) represents approximately 0.01% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Eton Pharmaceuticals, Inc. (ETON) was 118,300 shares, as reported at the end of Q4 2025.